PortfoliosLab logo

Pacific Biosciences of California, Inc. (PACB)

Equity · Currency in USD
Sector
Healthcare
Industry
Diagnostics & Research
ISIN
US69404D1081
CUSIP
69404D108

PACBPrice Chart


Chart placeholderClick Calculate to get results

PACBPerformance

The chart shows the growth of $10,000 invested in Pacific Biosciences of California, Inc. on Oct 28, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $12,451 for a total return of roughly 24.51%. All prices are adjusted for splits and dividends.


PACB (Pacific Biosciences of California, Inc.)
Benchmark (S&P 500)

PACBReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-26.76%-1.99%
6M-19.63%8.24%
YTD-21.09%20.83%
1Y13.72%23.70%
5Y24.32%15.68%
10Y23.05%13.72%

PACBMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

PACBSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Pacific Biosciences of California, Inc. Sharpe ratio is 0.10. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


PACB (Pacific Biosciences of California, Inc.)
Benchmark (S&P 500)

PACBDividends


Pacific Biosciences of California, Inc. doesn't pay dividends

PACBDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


PACB (Pacific Biosciences of California, Inc.)
Benchmark (S&P 500)

PACBWorst Drawdowns

The table below shows the maximum drawdowns of the Pacific Biosciences of California, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Pacific Biosciences of California, Inc. is 93.52%, recorded on Nov 13, 2012. It took 2026 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-93.52%Oct 29, 2010514Nov 13, 20122026Dec 1, 20202540
-59.98%Feb 12, 2021205Dec 3, 2021
-22.74%Jan 20, 20216Jan 27, 202110Feb 10, 202116
-11.19%Dec 9, 20207Dec 17, 20202Dec 21, 20209
-10.95%Dec 24, 20203Dec 29, 20206Jan 7, 20219
-9.43%Jan 11, 20212Jan 12, 20212Jan 14, 20214
-2.12%Jan 15, 20211Jan 15, 20211Jan 19, 20212

PACBVolatility Chart

Current Pacific Biosciences of California, Inc. volatility is 95.73%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


PACB (Pacific Biosciences of California, Inc.)
Benchmark (S&P 500)

Portfolios with Pacific Biosciences of California, Inc.


Loading data...

More Tools for Pacific Biosciences of California, Inc.